Echo-guided closure for atrial septal defect
Part of Genetic & congenital, Heart & circulation clinical trials.
This trial tests a new way to close a hole in the heart (atrial septal defect) using only ultrasound pictures, without X-rays. It may help people who want to avoid radiation or cannot have X-ray-guided procedures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 2 years old or older.
- You have a type of heart hole called a secundum atrial septal defect, sized between 6 and 36 millimeters.
- The hole is causing extra blood flow to the right side of your heart.
- The edges of the hole are far enough from important heart structures (at least 5 mm from certain veins and 7 mm from heart valves).
- You are not pregnant, do not have kidney problems, and have no allergy to contrast dye.
- You do not have other heart defects needing surgery, a right-to-left shunt, or a heart infection in the last month.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special balloon (AcuMark™ Sizing Balloon) to help doctors measure the exact size of a heart hole (atrial septal defect) before closing it. The goal is to make sure the closure device fits properly.
This trial tests a new way to close a common type of hole in the heart using a small tube inserted through a vein, all performed in a mobile surgical unit that can come to you. The goal is to improve access to this minimally invasive treatment.
This trial looks at whether a special 3D ultrasound picture helps doctors safely place a small device to close an atrial septal defect (ASD), a hole in the heart’s upper chambers. If you need ASD closure and are suitable for a device, the results could help improve guidance and outcomes.
This trial tests a new device that closes a common type of heart hole (atrial septal defect) and then dissolves over time. It may help reduce strain on the heart and improve symptoms without leaving a permanent implant.
This study follows up with patients who already received the Cera ASD occluder device to close a hole in the heart (atrial septal defect). It looks at how well the device is working over time and checks for any late problems.
This trial tests whether a medicine called dapagliflozin (usually used for diabetes or heart failure) helps the right side of the heart recover better after a procedure to close a hole in the heart (atrial septal defect). It may improve your heart's function and reduce strain after the closure.
Hear when a new Atrial Septal Defect (ASD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.